Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARB) Are Protective Against ICU Admission and Mortality for Patients With COVID-19 Disease

Introduction: Corona Virus disease 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) has become a global pandemic. The aim of this study was to investigate the impact of being on an Angiotensin-Converting Enzyme Inhibitors (ACEI) and/or Angiotensin Receptor B...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Front Med (Lausanne)
Egile Nagusiak: ElAbd, Rawan, AlTarrah, Dana, AlYouha, Sarah, Bastaki, Hamad, Almazeedi, Sulaiman, Al-Haddad, Mohannad, Jamal, Mohammad, AlSabah, Salman
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2021
Gaiak:
Medicine
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7969499/
https://ncbi.nlm.nih.gov/pubmed/33748156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2021.600385
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak